Cargando…

Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study

BACKGROUND: Chronic obstructive pulmonary disease (COPD) frequent exacerbators (FE) suffer increased morbidity and mortality compared to infrequent exacerbators (IE). The association between the oral and sputum microbiota and exacerbation phenotype is not well defined. The objective of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pragman, Alexa A., Knutson, Katherine A., Gould, Trevor J., Isaacson, Richard E., Reilly, Cavan S., Wendt, Chris H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555967/
https://www.ncbi.nlm.nih.gov/pubmed/31174538
http://dx.doi.org/10.1186/s12931-019-1080-4
_version_ 1783425246636802048
author Pragman, Alexa A.
Knutson, Katherine A.
Gould, Trevor J.
Isaacson, Richard E.
Reilly, Cavan S.
Wendt, Chris H.
author_facet Pragman, Alexa A.
Knutson, Katherine A.
Gould, Trevor J.
Isaacson, Richard E.
Reilly, Cavan S.
Wendt, Chris H.
author_sort Pragman, Alexa A.
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) frequent exacerbators (FE) suffer increased morbidity and mortality compared to infrequent exacerbators (IE). The association between the oral and sputum microbiota and exacerbation phenotype is not well defined. The objective of this study was to determine key features that differentiate the oral and sputum microbiota of FEs from the microbiota of IEs during periods of clinical stability. METHODS: We recruited 11 FE and 11 IE who had not used antibiotics or systemic corticosteroids in the last 1 month. Subjects provided oral wash and sputum samples, which underwent 16S V4 MiSeq sequencing and qPCR of 16S rRNA. Data were analyzed using Dada2 and R. RESULTS: FE and IE were similar in terms of age, FEV(1) percent predicted (FEV1pp), pack-years of tobacco exposure, and St. George’s Respiratory Questionnaire score. 16S copy numbers were significantly greater in sputum vs. oral wash (p = 0.01), but phenotype was not associated with copy number. Shannon diversity was significantly greater in oral samples compared to sputum (p = 0.001), and IE samples were more diverse than FE samples (p < 0.001). Sputum samples from FE had more Haemophilus and Moraxella compared to IE sputum samples, due to dominance of these COPD-associated taxa in three FE sputum samples. Amplicon sequencing variant (ASV)-level analysis of sputum samples revealed one ASV (Actinomyces) was significantly more abundant in IE vs. FE sputum (p(adj) = 0.048, Wilcoxon rank-sum test), and this persisted after controlling for FEV1pp. Principal coordinate analysis using Bray-Curtis distance with PERMANOVA analyses demonstrated clustering by anatomic site, phenotype, inhaled corticosteroid use, current tobacco use, COPD severity, and last professional dental cleaning. CONCLUSIONS: FE have less diverse oral and sputum microbiota than IE. Actinomyces was significantly more abundant in IE sputum than FE sputum. The oral and sputum microbiota of COPD subjects cluster based on multiple clinical factors, including exacerbation phenotype. Even during periods of clinical stability, the frequent exacerbator phenotype is associated with decreased alpha diversity, beta-diversity clustering, and changes in taxonomic abundance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1080-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6555967
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65559672019-06-10 Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study Pragman, Alexa A. Knutson, Katherine A. Gould, Trevor J. Isaacson, Richard E. Reilly, Cavan S. Wendt, Chris H. Respir Res Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) frequent exacerbators (FE) suffer increased morbidity and mortality compared to infrequent exacerbators (IE). The association between the oral and sputum microbiota and exacerbation phenotype is not well defined. The objective of this study was to determine key features that differentiate the oral and sputum microbiota of FEs from the microbiota of IEs during periods of clinical stability. METHODS: We recruited 11 FE and 11 IE who had not used antibiotics or systemic corticosteroids in the last 1 month. Subjects provided oral wash and sputum samples, which underwent 16S V4 MiSeq sequencing and qPCR of 16S rRNA. Data were analyzed using Dada2 and R. RESULTS: FE and IE were similar in terms of age, FEV(1) percent predicted (FEV1pp), pack-years of tobacco exposure, and St. George’s Respiratory Questionnaire score. 16S copy numbers were significantly greater in sputum vs. oral wash (p = 0.01), but phenotype was not associated with copy number. Shannon diversity was significantly greater in oral samples compared to sputum (p = 0.001), and IE samples were more diverse than FE samples (p < 0.001). Sputum samples from FE had more Haemophilus and Moraxella compared to IE sputum samples, due to dominance of these COPD-associated taxa in three FE sputum samples. Amplicon sequencing variant (ASV)-level analysis of sputum samples revealed one ASV (Actinomyces) was significantly more abundant in IE vs. FE sputum (p(adj) = 0.048, Wilcoxon rank-sum test), and this persisted after controlling for FEV1pp. Principal coordinate analysis using Bray-Curtis distance with PERMANOVA analyses demonstrated clustering by anatomic site, phenotype, inhaled corticosteroid use, current tobacco use, COPD severity, and last professional dental cleaning. CONCLUSIONS: FE have less diverse oral and sputum microbiota than IE. Actinomyces was significantly more abundant in IE sputum than FE sputum. The oral and sputum microbiota of COPD subjects cluster based on multiple clinical factors, including exacerbation phenotype. Even during periods of clinical stability, the frequent exacerbator phenotype is associated with decreased alpha diversity, beta-diversity clustering, and changes in taxonomic abundance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-019-1080-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-07 2019 /pmc/articles/PMC6555967/ /pubmed/31174538 http://dx.doi.org/10.1186/s12931-019-1080-4 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pragman, Alexa A.
Knutson, Katherine A.
Gould, Trevor J.
Isaacson, Richard E.
Reilly, Cavan S.
Wendt, Chris H.
Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
title Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
title_full Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
title_fullStr Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
title_full_unstemmed Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
title_short Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
title_sort chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555967/
https://www.ncbi.nlm.nih.gov/pubmed/31174538
http://dx.doi.org/10.1186/s12931-019-1080-4
work_keys_str_mv AT pragmanalexaa chronicobstructivepulmonarydiseaseupperairwaymicrobiotaalphadiversityisassociatedwithexacerbationphenotypeacasecontrolobservationalstudy
AT knutsonkatherinea chronicobstructivepulmonarydiseaseupperairwaymicrobiotaalphadiversityisassociatedwithexacerbationphenotypeacasecontrolobservationalstudy
AT gouldtrevorj chronicobstructivepulmonarydiseaseupperairwaymicrobiotaalphadiversityisassociatedwithexacerbationphenotypeacasecontrolobservationalstudy
AT isaacsonricharde chronicobstructivepulmonarydiseaseupperairwaymicrobiotaalphadiversityisassociatedwithexacerbationphenotypeacasecontrolobservationalstudy
AT reillycavans chronicobstructivepulmonarydiseaseupperairwaymicrobiotaalphadiversityisassociatedwithexacerbationphenotypeacasecontrolobservationalstudy
AT wendtchrish chronicobstructivepulmonarydiseaseupperairwaymicrobiotaalphadiversityisassociatedwithexacerbationphenotypeacasecontrolobservationalstudy